venBio Partners LLC
- SEC CIK
- 0001776382
- Latest filing
- Aug 14, 2026
Holdings in Q4 2024
Holdings as of Dec 31, 2024, filed Feb 14, 2025. Long positions only; changes compare share counts with Q3 2024.
- Positions
- 7
- +1 vs. Q3 2024
- Portfolio value
- $170.7M
- −$23.6M (−12.2%) vs. Q3 2024
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| PHVSPharvaris N.V. | COM | 4,289,304 | $82.2M | 48.2% | 00.0% | Unchanged | History |
| ALMSAlumis Inc. | COM | 2,787,398 | $21.9M | 12.8% | −38,650−1.4% | Reduced | History |
| HRMYHarmony Biosciences Holdings, Inc. | COM | 539,194 | $18.6M | 10.9% | −75,400−12.3% | Reduced | History |
| ALXOAlx Oncology Holdings Inc | COM | 9,699,925 | $16.2M | 9.5% | 00.0% | Unchanged | History |
| ARTVArtiva Biotherapeutics, Inc. | COM | 1,519,971 | $15.3M | 9.0% | 00.0% | Unchanged | History |
| SLRNACELYRIN, Inc. | COM | 3,806,410 | $12.0M | 7.0% | −46,060−1.2% | Reduced | History |
| LYELLyell Immunopharma, Inc. | COM | 7,102,190 | $4.55M | 2.7% | +7,102,190 | New | History |